about
Erythropoietin: new directions for the nervous systemCutting through the complexities of mTOR for the treatment of strokeTargeting disease through novel pathways of apoptosis and autophagyShedding new light on neurodegenerative diseases through the mammalian target of rapamycinNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseAn activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E⁻/⁻ mice.CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapyOvernutrition, mTOR signaling, and cardiovascular diseases.Inhibition of mTORC1 renders cardiac protection against lipopolysaccharide.A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeWnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.Novel directions for diabetes mellitus drug discoveryTuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.Rapamycin treatment of healthy pigs subjected to acute myocardial ischemia-reperfusion injury attenuates cardiac functions and increases myocardial necrosis.Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining studyMechanistic perspectives of calorie restriction on vascular homeostasis.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR.Activation of mTOR: a culprit of Alzheimer's disease?Potential therapeutic effects of mTOR inhibition in atherosclerosis.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in db/db Mice Skeletal Muscle.Novel insights in the metabolic syndrome-induced oxidative stress and inflammation-mediated atherosclerosis.The Protective Effect of Selenium on the Chicken Pancreas against Cadmium Toxicity via Alleviating Oxidative Stress and Autophagy.mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice.Bioactive components and mechanisms of Chinese poplar propolis alleviates oxidized low-density lipoprotein-induced endothelial cells injury.
P2860
Q26828425-1925C892-D82E-44C5-9C60-A8E5C4223A92Q26851291-17BB47DC-748F-40B0-85A2-432B746A8BA8Q26864639-3BB6F690-CCE6-4789-87AA-0C2CC9189544Q27015640-0F8CAF04-C718-4E0B-A0E3-9783A11EDA4FQ28080679-DE3BB9D3-B891-47F8-8E28-50B6B1FDFD1DQ28085715-A7C6DB58-71B8-42F7-AB76-32D2F8BD7FD4Q33827198-5B945499-AEB0-4D61-939F-35B96DC1FF7EQ33993634-BC84A704-4024-4907-AB35-753ADED738DEQ34519316-54F8D01D-A56B-42E3-BFAD-C4412F717D78Q35038438-303AA3FC-BC23-47B0-8F82-95B455B1ED72Q36379761-8C9D3E55-E8A1-4E98-BC32-F813CDC55020Q36432388-7D7C2E3F-65F8-4B52-B51C-722412A4B581Q36465550-6BEA6C77-5C8F-4787-B2B6-0FEFFFF7E3C3Q36487424-3D0DED93-3263-4A1E-86E1-5D14F39CE898Q36597635-D3CA7885-7837-4878-AB6D-0892384BD090Q37469455-37819F76-BE98-4939-9870-292A47B953FFQ37619336-FE829BEC-06C8-4462-A3FB-0F3B65301FB4Q37719815-4A9E56E3-2755-4CF9-A72F-4D03E21839F0Q38238017-C9A39E9D-819B-4CBB-9115-F72B7EA4EEB1Q38367977-B9D1345B-33D4-4685-A802-0A8994CF4EE5Q38368556-54221A1F-CE92-4CDA-BC38-43D7C11B752FQ38443497-27614DEB-4968-40C1-8EC0-4556431F42D3Q38628797-74125CF9-471E-4276-9B1E-703ACCCC48A0Q38655453-BC35B033-5B2A-440F-B4FE-904A97F66E01Q39180915-3F29F1AA-5D68-4913-8E67-F5D56A046E87Q39284965-43FDF527-256D-4D40-8789-BA8C1EAD3BC3Q47104031-F114A48E-2341-47F1-98D3-234758CB7CD3Q47248842-3B6DBCEE-6674-4260-9566-FB90CFA7860FQ47673476-7B636A60-014D-48E2-9858-FDB6AFABC62CQ47953822-A9867F52-F20D-4B8F-AA5B-8F75D4E7C3A8Q51018362-30A3C675-6307-498C-B155-ACC8F032012EQ52640082-8AA000C9-162C-4547-8B1C-451210FE6981Q54979811-AEA4F8D7-05AF-4CFE-9660-12825216CFFE
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cardiovascular disease and mTOR signaling
@ast
Cardiovascular disease and mTOR signaling
@en
type
label
Cardiovascular disease and mTOR signaling
@ast
Cardiovascular disease and mTOR signaling
@en
prefLabel
Cardiovascular disease and mTOR signaling
@ast
Cardiovascular disease and mTOR signaling
@en
P2093
P2860
P1476
Cardiovascular disease and mTOR signaling
@en
P2093
Kenneth Maiese
Yan Chen Shang
Zhao Zhong Chong
P2860
P304
P356
10.1016/J.TCM.2012.04.005
P577
2011-07-01T00:00:00Z